Non-deletional CD8 T cell self-tolerance
Non-deletional CD8 T cell self-tolerance
批准号:
10688010
负责人:
STEPHEN C JAMESON
金额:
$35.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-15 至 2024-08-31
关键词:
ATAC-seqAccelerationAcuteAddressAlopecia AreataAntigensApoptosisApoptoticAutoantigensAutoimmuneAutoimmune DiseasesAutoimmunityAutomobile DrivingAvidityBiological ModelsCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCell DeathCellsChromatinClinicalClonal DeletionDataDefectEnvironmentExposure toFrequenciesGene ExpressionGenesHealthHumanImmune systemImmunizationImmunotherapyIn VitroInbred MouseInfectionInfectious Skin DiseasesInflammationKnowledgeLaboratory miceLeftMaintenanceMediatingMicrobeMinnesotaMinorModelingMolecularMusMutateNormal tissue morphologyPathway interactionsPeripheralPhenotypePhysiologicalPlayPsoriasisRecording of previous eventsRegulatory T-LymphocyteReportingRoleSelf ToleranceSkinT cell anergyT cell responseT-Cell ActivationT-LymphocyteTestingUniversitiesVitiligoWild Type MouseWorkanergyautoreactive T cellautoreactivitycancer immunotherapyexhaustionexperienceimmunopathologyimprovedin vivomelanocytemelanomamicrobialmouse modelpreventrecruitresponsetranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
Self-tolerance requires that auto-reactive T cells either be physically eliminated, sequestered away from self-
antigen and/or incapacitated in their response to normal tissues. There have been many studies on deletional
tolerance and “ignorance” of self-antigens among CD8+ T cells, but much less is understood about how anergy
regulates that response T cell response. Studies on this issue are especially urgent, since recent data suggest
that anergy is the prevalent mechanism of CD8+ T cell self-tolerance in humans – but we lack appropriate
mouse models to investigate this critical mechanism. We address this issue with studies on mouse CD8+ T
cells that recognize the normal melanocyte antigens, which we demonstrate are tolerant through a form of cell-
intrinsic anergy. In Aim 1, we explore the basis for this anergy, building on preliminary studies to investigate
whether self-reactive CD8+ T cells are prone to apoptotic cell death following activation and using RNA-seq
and ATAC-seq approaches to define the gene expression and chromatin accessibility status of anergic versus
functional CD8+ T cells. In Aim 2, we test the reversibility of anergy, evaluating the role of continued self-
antigen exposure in maintaining this state, and we formally explore the potential role of Treg, as a cell-extrinsic
mechanism of inducing or perpetuating CD8+ T cell anergy. Finally, in Aim 3, we examine how the lack of
physiological exposure to normal skin infections and inflammation may compromise the value of current mouse
models for induction of autoimmune vitiligo (destruction of normal melanocytes following breakdown of CD8+ T
cell self-tolerance to melanocyte antigens). Our studies utilize models of acute skin inflammation and infection,
and also inbred mice that have been naturally infected with normal mouse microbes (“normal microbial
experience” mice, also called “dirty” mice) – a model which we developed at the University of Minnesota to
enhance mouse studies with improved relevance to humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of T cell responses by P2RX7
-
批准号:10393494
-
项目类别:
-
资助金额:$55.07万
-
财政年份:2019
-
负责人:STEPHEN C JAMESON
-
依托单位:
Regulation of T cell responses by P2RX7
-
批准号:10605308
-
项目类别:
-
资助金额:$55.07万
-
财政年份:2019
-
负责人:STEPHEN C JAMESON
-
依托单位:
The impact of IL-4 on the CD8 T cell response to pathogens
-
批准号:8293998
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2012
-
负责人:STEPHEN C JAMESON
-
依托单位:
The impact of IL-4 on the CD8 T cell response to pathogens
-
批准号:8424945
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2012
-
负责人:STEPHEN C JAMESON
-
依托单位:
Homeostatic Proliferation and Memory CD8 T Cells
-
批准号:8660594
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2008
-
负责人:STEPHEN C JAMESON
-
依托单位:
Homeostatic Proliferation and Memory CD8 T Cells
-
批准号:7609195
-
项目类别:
-
资助金额:$36.54万
-
财政年份:2008
-
负责人:STEPHEN C JAMESON
-
依托单位:
Homeostatic Proliferation and Memory CD8 T Cells
-
批准号:8502797
-
项目类别:
-
资助金额:$35.72万
-
财政年份:2008
-
负责人:STEPHEN C JAMESON
-
依托单位:
Homeostatic Proliferation and Memory CD8 T Cells
-
批准号:8261080
-
项目类别:
-
资助金额:$35.79万
-
财政年份:2008
-
负责人:STEPHEN C JAMESON
-
依托单位:
Homeostatic Proliferation and Memory CD8 T Cells
-
批准号:8822792
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2008
-
负责人:STEPHEN C JAMESON
-
依托单位:
Homeostatic Proliferation and Memory CD8 T Cells
-
批准号:8051809
-
项目类别:
-
资助金额:$35.8万
-
财政年份:2008
-
负责人:STEPHEN C JAMESON
-
依托单位:
Homeostatic Proliferation and Memory CD8 T Cells
-
批准号:7799139
-
项目类别:
-
资助金额:$36.17万
-
财政年份:2008
-
负责人:STEPHEN C JAMESON
-
依托单位:
Homeostatic Proliferation and Memory CD8 T Cells
-
批准号:9045541
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2008
-
负责人:STEPHEN C JAMESON
-
依托单位:
Homeostatic Proliferation and Memory CD8 T Cells
-
批准号:7456263
-
项目类别:
-
资助金额:$13.92万
-
财政年份:2008
-
负责人:STEPHEN C JAMESON
-
依托单位:
Homeostatic Proliferation and Memory CD8 T Cells
-
批准号:7497249
-
项目类别:
-
资助金额:$37.15万
-
财政年份:2007
-
负责人:STEPHEN C JAMESON
-
依托单位:
Developing epicutaneous vaccine approaches for protective immunity
-
批准号:7269391
-
项目类别:
-
资助金额:$36.46万
-
财政年份:2006
-
负责人:STEPHEN C JAMESON
-
依托单位:
Developing epicutaneous vaccine approaches for protective immunity
-
批准号:7134620
-
项目类别:
-
资助金额:$36.49万
-
财政年份:2006
-
负责人:STEPHEN C JAMESON
-
依托单位:
Developing epicutaneous vaccine approaches for protective immunity
-
批准号:7673597
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2006
-
负责人:STEPHEN C JAMESON
-
依托单位:
Developing epicutaneous vaccine approaches for protective immunity
-
批准号:7483275
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2006
-
负责人:STEPHEN C JAMESON
-
依托单位:
Developing epicutaneous vaccine approaches for protective immunity
-
批准号:7895857
-
项目类别:
-
资助金额:$38.6万
-
财政年份:2006
-
负责人:STEPHEN C JAMESON
-
依托单位:
CD8 T cell response to vaccinia following lymphopenia
-
批准号:6946855
-
项目类别:
-
资助金额:$29.11万
-
财政年份:2003
-
负责人:STEPHEN C JAMESON
-
依托单位:
海外基金